Scleroderma Therapeutics Market to Reach USD 4.49 Billion by 2035; Rising Focus on Targeted Therapies and Advancements in Autoimmune Disease Research Driving Market Growth ...

Growing Burden of Autoimmune Disorders, Expanding Biologic Pipeline, and Increasing Orphan Drug Support Accelerate Market Expansion.Austin, United States, March 19, 2026 (GLOBE NEWSWIRE) -- ...
Rochester Institute of Technology

RIT research could slow fibrosis disease progression

RIT biomedical engineering researchers identify a protein that can reduce fibrosis and slow disease progression.
The American Journal of Managed Care

Balancing Efficacy, Equity, and Shared Decision-Making in MS Care: Fred Lublin, MD

Fred D. Lublin, MD, discusses therapy sequencing, deescalation, health equity, and the future of multiple sclerosis (MS) care ...
BMJ Case Reports

Diagnostic and treatment challenges associated with the atypical presentation of ALK-positive anaplastic large cell lymphoma in a Jehovah’s Witness patient

A male in his 50s presented with profound leucocytosis, systemic symptoms and marked hepatosplenomegaly. Initial workup with peripheral blood flow cytometry suggested T-cell prolymphocytic leukaemia ...
Healio

FDA grants fast track designation to nipocalimab for adults with lupus

The FDA has granted fast track designation to the anti-FcRn agent nipocalimab for the treatment of adults with systemic lupus ...
Medscape

Therapy Insight: Scleritis And Its Relationship To Systemic Autoimmune Disease

Seronegative spondyloarthropathies -- ankylosing spondylitis, reactive arthritis, psoriatic arthritis 0.3-3.5 Polyarteritis nodosa 0.4-1.1 a Data are derived from three large series. Other systemic ...
Scientific Research Publishing

A Multimodal Machine-Learning Framework for Predicting Lithium-Associated Renal Dysfunction from Synthetic Biomarker Trajectories ()

Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant ...